Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
Go back to Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress| (NASDAQ: CABA) | Delayed: 3.35 +0.10 (3.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.25 | 52 Week High | $ | |||
| Open | $3.24 | 52 Week Low | $ | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $ | |||
| Volume | 1,559,223 | |||||
| (NASDAQ: CABA) | Delayed: 3.35 +0.10 (3.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.25 | 52 Week High | $ | |||
| Open | $3.24 | 52 Week Low | $ | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $ | |||
| Volume | 1,559,223 | |||||

